Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
XOMA Corporation
NASDAQ XOMAO
Data sourced from
and
and
XOMA Corporation EBIT 1 year YoY Change (%) for the quarter ending March 31, 2024: 31.13%
XOMA Corporation EBIT 1 year YoY Change (%) is 31.13% for the quarter ending March 31, 2024. EBIT, or Earnings Before Interest and Taxes, is calculated as operating income plus non-operating income. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
-
XOMA Corporation EBIT for the quarter ending March 31, 2023 was USD -10.17 M.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: XOMAO
| CEO | - |
| IPO Date | April 12, 2021 |
| Location | United States |
| Headquarters | 2200 Powell Street, EmeryVille, CA, United States, 94608 |
| Employees | 13 |
| Sector | Healthcare |
| Industry | Biotechnology |
Description
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Key trends
Similar companies
XOMA Corp
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email